Benzinga - Tue, 30 Mar 2021 06:03:24 -0400
Benzinga - Thu, 25 Mar 2021 08:05:59 -0400
Benzinga - Wed, 24 Mar 2021 08:06:45 -0400
Benzinga - Mon, 08 Mar 2021 11:04:39 -0400
Benzinga - Mon, 08 Mar 2021 10:31:34 -0400
Benzinga - Mon, 08 Mar 2021 08:53:25 -0400
Benzinga - Mon, 08 Mar 2021 08:20:45 -0400
Benzinga - Mon, 08 Mar 2021 07:21:24 -0400
Benzinga - Tue, 02 Mar 2021 13:48:16 -0400
Benzinga - Tue, 02 Mar 2021 11:41:55 -0400
Benzinga - Fri, 26 Feb 2021 06:27:31 -0400
Benzinga - Thu, 25 Feb 2021 13:35:09 -0400
Benzinga - Thu, 25 Feb 2021 13:28:11 -0400
Benzinga - Thu, 25 Feb 2021 09:46:28 -0400
Benzinga - Thu, 25 Feb 2021 09:08:03 -0400
load more
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-04
REV
Q4 2020Est.ActualSurprise
EPS-0.400-0.600 -0.2000
REV51.160M56.699M5.539M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AKBAAkebia Therapeutics1.12%478.2M

Akebia Therapeutics Company Questions & Answers

Q

How do I buy Akebia Therapeutics (AKBA) stock?

A

You can purchase shares of Akebia Therapeutics (NASDAQ: AKBA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Akebia Therapeutics's (AKBA) main competitors?

A

There are no as such competitors for Akebia Therapeutics.

Q

What is the target price for Akebia Therapeutics?

A

The latest price target for Akebia Therapeutics (NASDAQ: AKBA) was reported by Cantor Fitzgerald on 2021-03-08. The analyst firm set a price target for 8.00 expecting AKBA to rise to within 12 months (a possible 156.82% upside). 13 analyst firms have reported ratings in the last year.

Q

How much is Akebia Therapeutics (AKBA) stock ?

A

The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $3.115 last updated Today at 8:00:03 PM.

Q

When is the next Akebia Therapeutics (AKBA) dividend?

A

There are no upcoming dividends for Akebia Therapeutics.

Q

When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?

A
Akebia Therapeutics’s Q1 earnings are confirmed after-market from now on May 4, 2021.
Q

When is the upcoming split for AKBA?

A

There is no upcoming split for Akebia Therapeutics.